Replies to post #134566 on Biotech Values

[kris_kade]

Dew, I was referring to the cautious comments by ML Analyst Rachel McMinn not too long ago. Bristol-Meyers must have long back started doing their homework while such analysts have been clueless. I bet lot of her clients are not happy now..